Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

Strides Arcolab Gets U.S. Approval for Doxorubicin Injection

Don't Miss Out —
Follow us on:

Nov. 1 (Bloomberg) -- Onco Therapies Ltd., a unit of Indian drugmaker Strides Arcolab Ltd., received approval from the U.S. Food and Drug Administration for its doxorubicin chemotherapy injection, according to a statement on the FDA website.

Link to Company News:{3400398Z US <Equity> CN <GO>} Link to Company News:{STR IN <Equity> CN <GO>}

To contact the reporter on this story: Adi Narayan in Mumbai at anarayan8@bloomberg.net

To contact the editor responsible for this story: Hari Govind at hgovind@bloomberg.net